Ricerca avanzata

Home > Riviste > Minerva Chirurgica > Fascicoli precedenti > Minerva Chirurgica 2014 Giugno;69(3) > Minerva Chirurgica 2014 Giugno;69(3):147-53

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA CHIRURGICA

Rivista di Chirurgia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877

 

Minerva Chirurgica 2014 Giugno;69(3):147-53

 ARTICOLI ORIGINALI

A new prognostic strategy for gastric carcinoma: albumin level and metastatic lymph node ratio

Isik A. 1, Okan I. 2, Firat D. 1, Yilmaz B. 3, Akcakaya A. 4, Sahin M. 2

1 Department General Surgery, Erzincan University Hospital, Erzincan Turkey;
2 Department General Surgery, Gaziosmanpasa University Hospital, Tokat, Turkey;
3 Department of General Surgery, Acipayam State Hospital, Denizli, Turkey;
4 Department of General Surgery, Bezmi Alem University Hospital, Istanbul, Turkey

AIM: We evaluated the prognostic significance of preoperative serum albumin value and metastatic lymph node ratio for gastric cancer patients.
METHODS: We studied patients diagnosed with gastric carcinoma in the first Department of Surgery, Bezmialem Vakif Gureba Training and Research Hospital between January 2004 and December 2010; the patients were studied retrospectively.
RESULTS: A total of 67 patients with a mean age of 58.7±11.4 years were included in the study. The majority of patients were male (N.=53 male; N.=14 female). Most patients were in an advanced stage of the disease (stage III-IV) on admission (67.2%). We classified patients according to albumin value as “normal” Group 1 (83%) and “hypoalbuminemic” Group 2 (17%). With albumin, age, resection type, perineural invasion, and ratio of metastatic lymph nodes, T and TNM stages were significant predictors of cancer-specific survival.
CONCLUSION: As a result, irrespective of mechanism, pre-operative evaluations of albumin and metastatic lymph node ratio should be performed to stratify the patients for risk analysis and prognosis. A level less than 3.5 g/dL is a negative prognostic factor for resectable gastric cancers.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina